1. 111OMechanism informs precision: In vivo determinants of response to anti-CTLA-4 antibodies. (16th September 2018) Authors: Furness, A J S; Arce Vargas, F; Litchfield, K; Rosenthal, R; Gore, M; Larkin, J; Turajlic, S; Swanton, C; Peggs, K; Quezada, S Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1836PDRepresentative sequencing: Profiling extreme tumor diversity. (23rd October 2018) Authors: Litchfield, K; Au, L; Swanton, C; Turajlic, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 7OContrasting the drivers of response to immunotherapy across solid tumour types: Results from analysis of > 1000 cases. (7th November 2019) Authors: Litchfield, K; Swanton, C; Turajlic, S; McGranahan, N; Quezada, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma. (7th February 2019) Authors: Shepherd, S T C; Litchfield, K; Turajlic, S Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗